This volume tackles the applications and implications of carbon nanotubes in biology and medicine, from their unique promise in biotechnologies, to controversies about toxicology. Guided by carbon nanomaterials experts, editors Dr Daniel Heller and Dr Mijin Kim, multiple viewpoints are engaged.Carbon nanotubes emerged as one of the most exciting nanomaterials in the 1990s due to their unique chemical, physical, and electrical properties. Because of the work over the past three decades, carbon nanotubes are now the subject of intense research for the development of new biomedical technologies. The authors' goal with this book series is to enable readers to understand the exciting properties of carbon nanotubes of use for biomedical research and devices, and the cutting edge of the development of carbon nanotube-based imaging agents, drug and gene delivery carriers, and nanosensor research. Readers will learn about the potential impact of carbon nanotubes on chemical biology and medicine and understand the opportunities of carbon nanotubes to address biological and biomedical questions that are inaccessible with conventional tools in research labs and the clinic.The book also discusses how artificial intelligence is facilitating the innovation in carbon nanotube research in biomedicine, the controversial toxicological issues with nanotubes, and the remaining challenges and policy considerations for the broad adoption of carbon nanotechnologies.